about
Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient RegistryExercise limitations and training for patients with cystic fibrosisInhaled antibiotics for the treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients: challenges to treatment adherence and strategies to improve outcomesExacerbations in cystic fibrosis: 2 . prevention.Individualised unsupervised exercise training in adults with cystic fibrosis: a 1 year randomised controlled trial.Determinants of adherence in adults with cystic fibrosis.Perceptions of barriers and facilitators: self-management decisions by older adolescents and adults with CF.Factors that influence adherence to exercise and their effectiveness: application to cystic fibrosis.The role of galenic innovation in improving treatment compliance and persistence: three case studies.Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis.Macrolides in cystic fibrosis: is there a role?Physiotherapy management of cystic fibrosis.Health perceptions and treatment adherence in adults with cystic fibrosis.Compliance with treatment in adult patients with cystic fibrosisDifferent perceptions of disease severity and self care between patients with cystic fibrosis, their close companions, and physician.Communicating with young adults with cystic fibrosisExercise and sport in cystic fibrosis: benefits and risksEffects of changes in lung volume on oscillatory flow rate during high-frequency chest wall oscillationEnhancing adherence to inhaled therapies in cystic fibrosis.Death after cessation of treatment by cystic fibrosis patients: An international survey of clinicians.Pulmonary Pharmacokinetics of Colistin Following Administration of Dry Powder Aerosols in Rats.Adherence to chest physiotherapy in adults with cystic fibrosis.Adherence pattern to study drugs in clinical trials by patients with cystic fibrosis.Contemporary psychosocial issues in cystic fibrosis: treatment adherence and quality of life.Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis.Is prolonged rotavirus infection a common cause of protracted diarrhoea?Evidence for using nebulised antibiotics in cystic fibrosis.Transplanting the adolescent cystic fibrosis patient: can we do it?Supporting parents in managing drugs for children with cystic fibrosis.Adherence and Recursive Perception Among Young Adults with Cystic Fibrosis.Pharmacological management of cystic fibrosis related diabetes.Adherence to treatment in adolescents with cystic fibrosis: the role of illness perceptions and treatment beliefs.Understanding Treatment Adherence With the Health Belief Model in Children With Cystic Fibrosis.Why bother to take vitamins?Life-space mobility is associated with frequency of hospitalization in adults with cystic fibrosis.Influence of the Vibralung Acoustical Percussor on pulmonary function and sputum expectoration in individuals with cystic fibrosis.
P2860
Q22305306-24BB3BD2-5849-4A88-9DD3-3213A7692731Q22305697-3D6E9364-502D-4B23-9A7D-038EA3BE0F9FQ26764900-42BDCA21-B351-4AAE-B8B8-9280321E112FQ30480308-4B63B957-11E4-4AE0-9255-5D2DDA88D699Q33983327-2F90F54E-3DD3-4A94-A0F1-322EECC8CBA3Q34616202-816C3A7C-FC48-4EC2-A365-60B00779B8E1Q34626828-95970B46-3351-40F5-B271-B44867086B18Q34733551-DC610926-53E0-4151-869F-C3753D99044DQ35454381-E58DD0AE-B780-44B1-8A02-538F6D5A964EQ35535029-598525FB-6D4C-4CF5-9B26-CF2932F7DD5CQ35563665-0B195240-4E0B-4895-BA52-8E778D34F6C7Q35627801-A007511B-223E-464C-9715-F790CB7E73A2Q36310742-4D865E28-CD45-4C9D-B009-6055DDE6A7E8Q36504739-18AAAB35-E30D-4934-BF69-F06D4EE8DEBCQ36505302-E7F2BC06-7BF3-4E92-A4B6-FE2A85D88FE5Q36559804-0A99F3A5-71BB-4315-A19B-95390CC4B9CCQ36679770-D7B586E8-A1A0-4EE0-B374-7483EB73C3E6Q37100677-B96EE86C-12AA-4594-9DEE-DBBBCED382C1Q37178571-58C0E0E4-C491-4D74-9379-1FF9E3E2B129Q38193291-B72A00D1-768F-43A5-BEE0-2E312355D159Q39918757-BAF21DAD-E196-46B7-8DBB-F3E07A1233B4Q40093588-796E96BA-4E52-4716-AB90-83D1709AA208Q40279934-17548D3C-D5FE-4100-A9B5-D426CE11135BQ40304857-9294684C-B618-4742-A7F9-FEF751F81179Q40854258-68DE2416-4961-42F4-844F-BE604892EFFAQ41847225-0A7FBF3E-F6CB-408C-B1D5-5696256359B2Q42143890-7CBC4B17-7E20-45A4-9969-CB2D5C8965FFQ43102413-2271E97B-149C-41A2-A418-D6120084D594Q44145586-AF6CB515-2F66-469E-AE75-4401F2EC5367Q45169084-A16736A7-220D-45D6-AD32-0B2B40B8126FQ47227863-A900105C-A573-4674-BA5D-9AAB480262E7Q47266208-5FABF257-D8DD-4B4B-A5D3-098EC7A03863Q47620270-145B75A6-F4A2-4531-98F0-F8EE8DD761CFQ47900705-7521859F-0CC1-4351-A7E5-79A091A89060Q52845393-25475067-AB45-4F13-9D30-4176EC3459D5Q53029501-1538D213-3B55-46F9-A6DF-8D5290787117Q55454926-E163868A-F4DD-4FD2-9531-7EA44086565C
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Treatment compliance in adults with cystic fibrosis.
@ast
Treatment compliance in adults with cystic fibrosis.
@en
type
label
Treatment compliance in adults with cystic fibrosis.
@ast
Treatment compliance in adults with cystic fibrosis.
@en
prefLabel
Treatment compliance in adults with cystic fibrosis.
@ast
Treatment compliance in adults with cystic fibrosis.
@en
P2093
P2860
P356
P1433
P1476
Treatment compliance in adults with cystic fibrosis.
@en
P2093
P2860
P304
P356
10.1136/THX.49.2.115
P407
P577
1994-02-01T00:00:00Z